Home/Filings/4/A/0000899243-18-029696
4/A//SEC Filing

Reeg Christopher C 4/A

Accession 0000899243-18-029696

CIK 0000319016other

Filed

Nov 26, 7:00 PM ET

Accepted

Nov 27, 6:56 PM ET

Size

8.6 KB

Accession

0000899243-18-029696

Insider Transaction Report

Form 4/AAmended
Period: 2018-08-01
Reeg Christopher C
DirectorChief Executive Officer10% Owner
Transactions
  • Purchase

    Common Stock

    2018-08-01$0.76/sh+2,539,474$1,930,0006,539,474 total(indirect: By Reeg Medical Industries, Inc.)
  • Purchase

    Common Stock

    2018-10-04$0.68/sh+72,139$49,0556,611,613 total(indirect: By Reeg Medical Industries, Inc.)
Footnotes (4)
  • [F1]This Form 4/A amends the Form 4 filed by Christopher C. Reeg ("Reeg") on August 3, 2018, to correct the number of shares of common stock, par value $0.01 (the "Common Stock"), of the Fuse Medical, Inc., a Delaware corporation (the "Company"), that Reeg received pursuant to that certain Securities Purchase Agreement, dated July 30, 2018 (the "Maxim Purchase Agreement"), by and between the Company, Palm Springs Partners, LLC d/b/a Maxim Surgical, a Texas limited liability company ("Maxim"), Reeg Medical Industries, Inc., a Texas corporation ("RMI"), Mr. Amir David Tahernia, an individual ("Tahernia", together with RMI, the "Sellers"), and Tahernia in his capacity as the representative of the Sellers (the "Sellers Representative").
  • [F2](Continued from Footnote 1) The Company made a calculation error when computing the number of shares of Common Stock issued to RMI, and corrected the number in its Current Report on Form 8-K/A filed with the Securities and Exchange Commission (the "SEC") on November 16, 2018 (the "Maxim Form 8-K/A").
  • [F3]On October 4, 2018, the Company issued 72,139 shares of Common Stock to RMI, which represents RMI's pro rata share of the agreed-upon purchase price adjustment pursuant to Pursuant to the Maxim Purchase Agreement, as reported in the Maxim Form 8-K/A.
  • [F4]These securities are directly owned by RMI. Reeg is the sole shareholder, sole director, and sole officer of RMI. Accordingly, Reeg indirectly beneficially owns the reported securities.

Issuer

Fuse Medical, Inc.

CIK 0000319016

Entity typeother

Related Parties

1
  • filerCIK 0001688080

Filing Metadata

Form type
4/A
Filed
Nov 26, 7:00 PM ET
Accepted
Nov 27, 6:56 PM ET
Size
8.6 KB